Healthcare and Life Sciences in North America: Opportunities & Post-Pandemic Outlook December 12, 2022 Life Science
H1 2022 Healthcare and Life Sciences Worldwide: Cell and Gene Therapy (CGT) December 6, 2022 Life Science
H1 2022 Healthcare and Life Sciences in North America: Market Insights November 29, 2022 Life Science
RepliCel Ships DermaPrecise(TM) Injector Prototypes and Consumables to Independent Laboratory for Clinical Simulation Testing November 11, 2021 Life Science
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team November 9, 2021 Life Science
RepliCel Announces DermaPrecise Trademark for Dermal Injector Product Line October 28, 2021 Life Science
Looking for your next +30% opportunity? Join our multi-sector high growth stock virtual event October 27, 2021 Cannabis, Consumer Goods, Life Science, Technology
Hemostemix Confirms OTCQB Application is Filed October 19, 2021 Cannabis, Consumer Goods, Life Science, Technology
RepliCel Files Notice of Arbitration against Shiseido Company to Resolve its License Agreement Dispute Regarding its Androgenetic Alopecia Cell Therapy October 18, 2021 Cannabis, Consumer Goods, Life Science, Technology
Hemostemix Announces Dr. Fraser C. Henderson Sr., MD, as Chief Medical Officer October 14, 2021 Cannabis, Consumer Goods, Life Science, Technology
RepliCel Life Sciences Appoints One of Japan’s Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor October 12, 2021 Cannabis, Consumer Goods, Life Science, Technology
Hemostemix Announces the Second Stem Cell Recipient Interview: One Week to No Chest Pain October 4, 2021 Cannabis, Consumer Goods, Life Science, Technology
Insights into China’s Pharmaceutical Industry Trends from a 2,000-strong Industry Conference September 30, 2021 Life Science
